A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans

Malinin, Nikolay L.; Li Zhang; Choi, Jeongsuk; Ciocea, Alieta; Razorenova, Olga; Yan-Qing Ma; Podrez, Eugene A.; Tosi, Michael; Lennon, Donald P.; Caplan, Arnold I.; Shurin, Susan B.; Plow, Edward F.; Byzova, Tatiana V.
March 2009
Nature Medicine;Mar2009, Vol. 15 Issue 3, p313
Academic Journal
Monogenic deficiency diseases provide unique opportunities to define the contributions of individual molecules to human physiology and to identify pathologies arising from their dysfunction. Here we describe a deficiency disease in two human siblings that presented with severe bleeding, frequent infections and osteopetrosis at an early age. These symptoms are consistent with but more severe than those reported for people with leukocyte adhesion deficiency III (LAD-III). Mechanistically, these symptoms arose from an inability to activate the integrins expressed on hematopoietic cells, including platelets and leukocytes. Immortalized lymphocyte cell lines isolated from the two individuals showed integrin activation defects. Several proteins previously implicated in integrin activation, including Ras-associated protein-1 (RAP1) and calcium and diacylglycerol-regulated guanine nucleotide exchange factor-1 (CALDAG-GEF1), were present and functional in these cell lines. The genetic basis for this disease was traced to a point mutation in the coding region of the KINDLIN3 (official gene symbol FERMT3) gene. When wild-type KINDLIN-3 was expressed in the immortalized lymphocytes, their integrins became responsive to activation signals. These results identify a genetic disease that severely compromises the health of the affected individuals and establish an essential role of KINDLIN-3 in integrin activation in humans. Furthermore, allogeneic bone marrow transplantation was shown to alleviate the symptoms of the disease.


Related Articles

  • Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Svensson, Lena; Howarth, Kimberley; McDowall, Alison; Patzak, Irene; Evans, Rachel; Ussar, Siegfried; Moser, Markus; Metin, Ayse; Fried, Mike; Tomlinson, Ian; Hogg, Nancy // Nature Medicine;Mar2009, Vol. 15 Issue 3, p306 

    Integrins are the major adhesion receptors of leukocytes and platelets. β1 and β2 integrin function on leukocytes is crucial for a successful immune response and the platelet integrin αIIbβ3 initiates the process of blood clotting through binding fibrinogen. Integrins on circulating...

  • Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. Evans, A.L.; Bell, R.; Brice, G.; Comeglio, P.; Lipede, C.; Jeffery, S.; Mortimer, P.; Sarfarazi, M.; Child, A.H. // Journal of Medical Genetics;Sep2003, Vol. 40 Issue 9, p697 

    Describe families with primary congenital lymphoedema consistent with linkage to the 5q35.3 region. Clinical analysis of patients; Identification of eight novel mutations in VEGFR-3; Deletion of three nucleotides resulting in the deletion of phenylalanine.

  • A New Diagnostic Service For Rate Inherited Diseases. Marchbank, Nicola; Wallace, A.J.; Elles, R.G. // Journal of Medical Genetics;Sep2003 Supplement, Vol. 40, pS72 

    Purpose: As part of the National Genetics Reference Laboratory (NGRL) programme, a new rare disease testing service has been developed. The purpose of this service is to confirm mutations identified by research laboratories to diagnostic standards in order to provide predictive, pre-natal and...

  • Founder effect and estimation of the age of the French Gypsy mutation associated with Glanzmann thrombasthenia in Manouche families. Fiore, Mathieu; Pillois, Xavier; Nurden, Paquita; Nurden, Alan T.; Austerlitz, Frédéric // European Journal of Human Genetics;Sep2011, Vol. 19 Issue 9, p981 

    The c.1544+1G>A substitution at the 5′ splice donor site of intron 15 of the ITGA2B gene, called the French Gypsy mutation, causes Glanzmann thrombasthenia, an inherited hemorrhagic disorder transmitted as an autosomal recessive trait and characterized by an altered synthesis of the...

  • Patients with Hereditary Hemorrhagic Telangectasia (HHT) Exhibit a Deficit of Polymorphonuclear Cell and Monocyte Oxidative Burst and Phagocytosis: A Possible Correlation with Altered Adaptive Immune Responsiveness in HHT. Cirulli, Anna; Loria, Maria Paola; Dambra, Porzia; Di Serio, Francesca; Ventura, Maria T.; Amati, Luigi; Jirillo, Emilio; Sabbà, Carlo // Current Pharmaceutical Design;Apr2006, Vol. 12 Issue 10, p1209 

    Hereditary Hemorrhagic Telangiectasia (HHT) is a rare genetic disease characterized by mutations occurring in the endoglin and ALK-1, two receptors of transforming growth factor-β1. From a pathogenic point of view, a possible involvement of the immune system in HHT has been suggested since a...

  • Analysis ofKIT,SCF, and Initial Screening ofSLUGin Patients with Piebaldism. Tomoko Murakami; Naoko Hosomi; Naoki Oiso; Giovannucci-Uzielli, Maria Luisa; Aquaron, Robert; Masako Mizoguchi; Atsushi Kato; Masamitsu Ishii; Bitner-Glindzicz, Maria; Barnicoat, Angela; Wilson, Louise; Katsuhiko Tsukamoto; Hiroshi Ueda; Mancini, Anthony J.; Tamio Suzuki; Riley, Jacquely; Miertus, Jan; Camargo, Mauricio; Santoro-Zea, Alexandra; Atkin, Joan // Journal of Investigative Dermatology;Mar2005, Vol. 124 Issue 3, p670 

    Piebaldism is an autosomal dominant disorder, characterized by congenital leukoderma typically on the abdomen, knees, and forehead. Mice models for human piebaldism are theWdominant white spotting, thesteelmice and the mice that are mutated for thesluggene. Human genes for these mice models were...

  • Leukocyte adhesion deficiency syndrome: a controversy solved. Abram, Clare L.; Lowell, Clifford A. // Immunology & Cell Biology;Aug2009, Vol. 87 Issue 6, p440 

    The article focuses on the solved controversy of the leukocyte adhesion deficiency (LAD) syndrome III1-3. Accordingly, it is found that mutations in kindlin-3 is the cause of the said genetic disorder. It highlights the types of LAD syndromes including LAD I, LAD II and LADIII. It also notes on...

  • Prevalence and Clinical Significance of HFE Gene Mutations in Patients With Iron Overload. Brandhagen, D. J.; Fairbanks, V. F.; Baldus, W. P.; Smith, C. I.; Kruckeberg, K. E.; Schaid, D. J.; Thibodeau, S. N. // American Journal of Gastroenterology;Oct2000, Vol. 95 Issue 10, p2910 

    OBJECTIVE: The HFE gene contains two mutant alleles; C282Y and H63D. The C282Y mutation occurs in 55-100% of patients with hereditary hemochromatosis. The aim of our study was to re-examine the frequencies of the C282Y and H63D mutations in patients with mild and marked iron overload...

  • Molecular studies in 10 cases of Rubinstein-Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. Bartsch, O.; Locher, K.; Meinecke, P.; Kress, W.; Seemanová, E.; Wagner, A.; Ostermann, K.; Rödel, G. // Journal of Medical Genetics;Jul2002, Vol. 39 Issue 7, p496 

    Describes sequence variants of CREBBP, the gene for cyclic adenosine monophosphate responsive element binding protein, in ten subjects, including one showing a very mild phenotype of Rubinstein-Taybi syndrome and a missense mutation. Patient profiles; Fluorescence in situ hybridization and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics